Lv3
390 积分 2024-10-12 加入
Pediatric Acute Lymphoblastic Leukemia With Hypereosinophilia and IDH2 Gene Mutation: A Case Report and Literature Review
1个月前
已关闭
IDH1 mutation in acute lymphoblastic leukemia—A rare but significant finding
1个月前
已完结
Resistance to mutant IDH inhibitors in acute myeloid leukemia: Molecular mechanisms and therapeutic strategies
1个月前
已完结
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
2个月前
已完结
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
2个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
2个月前
已完结
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations
6个月前
已完结
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
6个月前
已完结
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
